Efficacy and Safety of Bevacizumab Plus Oxaliplatin- or Irinotecan-Based Doublet Backbone Chemotherapy as the First-Line Treatment of Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Bevacizumab Plus Oxaliplatin- or Irinotecan-Based Doublet Backbone Chemotherapy as the First-Line Treatment of Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.
Authors: Ren, Tianshu1,2, Wang, Shu1, Shen, Zexu1, Xu, Chang1, Zhang, Yingshi1, Hui, Fuhai1, Qi, Xingshun3, Zhao, Qingchun1,2 zhaoqingchun1967@163.com
Source: Drug Safety. 2021, Vol. 44 Issue 1, p29-40. 12p.
Database: Environment Complete
Description
ISSN:01145916
DOI:10.1007/s40264-020-00997-2